Synapse - Works

Results (13804)

Genomic and transcriptomic profiling of primary tumors from patients with HR+, HER2-, node-positive, high-risk early breast cancer (EBC) in the monarchE trial

Meeting Abstract

Rubenstein, C. S.; Turner, N.; Reis, J. S.; Goetz, M. P.; Desmedt, C.; Chandarlapaty, S.; Sasano, H.; Arteaga, C. L.; Loi, S.; Graff, S. L.; more...
Breast (2025)

Fulltext@MSK | Save

Prognostic utility of ctDNA detection in the monarchE trial of adjuvant abemaciclib plus endocrine therapy (ET) in HR+, HER2-, node-positive, high-risk early breast cancer (EBC)

Meeting Abstract

Loi, S.; Johnston, S.; Arteaga, C.; Graff, S.; Chandarlapaty, S.; Goetz, M.; Desmedt, C.; Sasano, H.; Liu, D.; Rodrik-Outmezguine, V.; more...
Breast (2025)

Fulltext@MSK | Save

Survival from ER-positive breast cancer in women who carry a BRCA1 mutation

Meeting Abstract

Narod, S.; Lubinski, J.; Wong, S.; Soukupova, J.; Bernstein, R.; Fruscio, R.; Plichta, J.; Lee, M.; Irmejs, A.; Evans, G.; more...
Breast (2025)

Fulltext@MSK | Save

Impact of bilateral surgery on time to treatment in patients with breast cancer undergoing mastectomy - A retrospective cohort study

Meeting Abstract

Heidinger, M.; Staehelin, S.; Halbeisen, F.; Maggi, N.; Loesch, J. M.; Schwab, F. D.; Kurzeder, C.; Montagna, G.; Weber, W. P.
Breast (2025)

Fulltext@MSK | Save

Osimertinib (osi) + datopotamab deruxtecan (Dato-DXd) in patients (pts) with EGFR-mutated (EGFRm) advanced NSCLC (aNSCLC) whose disease progressed on first-line (1L) osi: ORCHARD

Meeting Abstract

Le, X.; Hendriks, L.; Morabito, A.; Bonanno, L.; Okamoto, I.; Goldman, J. W.; Yu, H. A.; Brustugun, O. T.; Halvorsen, T. O.; Kim, Y. J.; more...
Journal of Thoracic Oncology (2025)

Fulltext@MSK | Save

Tepotinib in patients (pts) with METexon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes